AI-generated summary
The authors reviewed medical records of 202 patients with hemangioma treated with intense pulsed light (IPL) laser between 2009 and 2019 in Albania. They report on the procedure and aim to show efficacy and a good safety profile, with minor adverse events. The abstract does not report a formal outcome measure, and the study is a retrospective review.
- Participants
- 202
- Who or what was studied
- Patients diagnosed with superficial hemangioma treated with IPL laser in Albania, January 2009 to January 2019
- Wavelengths
- 590, 595 nm
- Limits stated in the abstract
- The abstract describes a retrospective record review without a control group and does not report quantitative efficacy results.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 590 to 595 nm
- Energy density (fluence)
- 12 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.